NewsRoom Articles - Page 1208 of 1451

WednesdayDec 06, 2017 7:30 pm

TheStreet, Inc. (NASDAQ: TST) Starts Presentation at LD Micro Main Event

TheStreet (NASDAQ: TST) provides timely unbiased news, data and analysis to help the world make informed investment decisions and discover new business opportunities. Executives and their advisors, retail and institutional investors and academics use TheStreet’s information and tools to navigate financial markets, corporate governance and dealmaking, 24/7, across every platform.TheStreet.com is a source for news, analysis and information of the financial markets, economy, sector trends, investment and financial planning. Its website includes free content and subscription products that combine expert commentary, state-of-the-art tools and interactive features that serve varying segments of the retail investing public. For more information, visit the…

WednesdayDec 06, 2017 7:00 pm

NanoVibronix, Inc. (NAOV) Starts Presentation at LD Micro Main Event

NanoVibronix (OTC: NAOV) is a medical device company focused on developing medical devices utilizing its proprietary and patented low intensity surface acoustic wave technology. The company's groundbreaking technology allows for the creation of low-frequency ultrasound waves that can be utilized for a variety of medical applications, including the disruption of biofilms and bacteria colonization, as well as providing pain relief. The devices can be administered at home, without the assistance of medical professionals. The company's products include PainShield® UroShield™ NG-Shield™ and WoundShield™. For more information, visit the company’s website at www.nanovibronix.com. About NetworkNewsWire NetworkNewsWire (NNW) is an information service that…

WednesdayDec 06, 2017 7:00 pm

CounterPath Corporation (NASDAQ: CPAH) Starts Presentation at LD Micro Main Event

CounterPath (NASDAQ: CPAH) is a global provider of award-winning, over-the-top (OTT) Unified Communications (UC) solutions for enterprises and carriers. The company’s Bria softphones for desktop, tablet and mobile devices, together with Stretto Platform™ server solutions, enable operators, OEMs and enterprises large and small around the globe to offer a seamless and unified over-the-top (OTT) communications experience across both fixed and mobile networks. Standards-based, cost-effective and reliable, CounterPath’s award-winning solutions power the voice and video calling, messaging, and presence offerings of customers such as AT&T, Avaya, BroadSoft, Cisco Systems, Mitel, NEC, Nokia, and Verizon. For more information, visit the company’s website…

WednesdayDec 06, 2017 7:00 pm

eMagin Corporation (NYSE: EMAN) Starts Presentation at LD Micro Main Event

eMagin (NYSE: EMAN) provides OLED microdisplay technology, OLED microdisplay manufacturing know-how and mobile display systems. eMagin manufactures high-resolution OLED microdisplays and integrates them with magnifying optics to deliver virtual images comparable to large-screen computer and television displays in portable, low-power, lightweight personal displays. eMagin’s microdisplays provide near-eye imagery in a variety of products from military, industrial, medical and consumer OEMs. For more information, visit the company’s website at www.emagin.com. About NetworkNewsWire NetworkNewsWire (NNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) NetworkNewsBreaks that summarize corporate news and information, (3) enhanced press release…

WednesdayDec 06, 2017 7:00 pm

Sigma Labs, Inc. (SGLB) Starts Presentation at LD Micro Main Event

Sigma Labs (OTC: SGLB) is a provider of quality assurance software under the PrintRite3D® brand and a developer of advanced, in-process, non-destructive quality assurance software for commercial firms worldwide seeking productive solutions for advanced manufacturing. For more information, visit the company’s website at www.sigmalabsinc.com. About NetworkNewsWire NetworkNewsWire (NNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) NetworkNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution…

WednesdayDec 06, 2017 7:00 pm

Simulations Plus, Inc. (NASDAQ: SLP) Starts Presentation at LD Micro Main Event

Simulations Plus (NASDAQ: SLP) is a premier developer of drug discovery and development software as well as a provider of both preclinical and clinical pharmacometric consulting services for regulatory submissions and quantitative systems pharmacology models for drug-induced liver injury and nonalcoholic fatty liver disease. The company’s software is licensed to and used in the conduct of drug research by major pharmaceutical, biotechnology, chemical, and consumer goods companies and regulatory agencies worldwide. For more information, visit the company’s website at www.simulations-plus.com. About NetworkNewsWire NetworkNewsWire (NNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2)…

WednesdayDec 06, 2017 6:30 pm

True Leaf Medicine International Ltd. (TRLFF) Starts Presentation at LD Micro Main Event

True Leaf Medicine International Ltd. (OTC: TRLFF) through its wholly owned subsidiary "True Leaf Pet,” has entered the global pet industry with a line of hemp-focused pet supplements in Canada, the United States and Europe. The company has also filed an application under Health Canada’s Access to Cannabis for Medical Purposes Regulations to become a Canadian licensed producer of medical cannabis through its "True Leaf Medicine” subsidiary. It has passed through the preliminary and enhanced screening process of Health Canada’s review and has recently received approval to build its facility. For more information, visit the company’s website at www.trueleaf.com. About…

WednesdayDec 06, 2017 6:30 pm

Oncolix, Inc. (AEPP) Starts Presentation at LD Micro Main Event

Oncolix (OTC: AEPP) is a clinical-stage biotechnology company developing Prolanta™ for the treatment of ovarian, uterine, breast and other cancers. The company has a US FDA-cleared IND to commence human testing of Prolanta™ in the treatment of ovarian cancer. Prolanta™ is a prolactin receptor antagonist that has demonstrated efficacy in xenograft models through a unique mechanism of action, autophagy. There is also strong preclinical evidence Prolanta™ may be effective in breast, prostate and other cancers. The FDA has approved the designation of Prolanta™ as an Orphan Drug for the treatment of ovarian cancer. For more information, visit the company’s website…

WednesdayDec 06, 2017 6:30 pm

Tonix Pharmaceuticals Holding Corp. (NASDAQ:TNXP) Starts Presentation at LD Micro Main Event

Tonix Pharmaceuticals (NASDAQ:TNXP) is developing innovative pharmaceutical and biological products to address major public health challenges. In addition to Tonmya for PTSD, Tonix is developing TNX-601 (tianeptine oxalate), a clinical candidate at pre-IND (Investigational New Drug) application stage, designed as a daytime treatment for PTSD and TNX-801, a live synthetic version of horsepox virus, at the pre-IND application stage, to be developed as a potential smallpox-preventing vaccine. For more information, visit the company’s website at www.tonixpharma.com. About NetworkNewsWire NetworkNewsWire (NNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) NetworkNewsBreaks that summarize corporate…

WednesdayDec 06, 2017 6:30 pm

Sorrento Therapeutics, Inc. (NASDAQ: SRNE) Starts Presentation at LD Micro Main Event

Sorrento Therapeutics (NASDAQ: SRNE) is a clinical stage, antibody-centric, biopharmaceutical company developing new therapies to turn malignant cancers into manageable and possibly curable diseases. Sorrento's multimodal multipronged approach to fighting cancer is made possible by its extensive immuno-oncology platforms, including key assets such as fully human antibodies, clinical stage immuno-cellular therapies, intracellular targeting antibodies, antibody-drug conjugates, and clinical stage oncolytic virus. Sorrento's is also advancing a first-in-class (TRPV1 agonist) non-opioid pain management small molecule in Resiniferatoxin and ZTlido. Resiniferatoxin is completing a phase IB trial in terminal cancer patients. ZTlido is in regulatory review. For more information, visit the company’s…